Since we have shown that IL-36Ra is downregulated in COPD subjects and may exacerbate the inflammatory response of IL-36 cytokines in the COPD lung, we investigated whether reintroduction of IL-36Ra could inhibit IL-36γ–driven inflammation. Here, IL36G is linked to chronic obstructive pulmonary disease.